Notice names this product. Bionpharma’s Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg is named in FDA Class III recall D-0822-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Presence of Foreign Tablets/Capsules Identifying details: Lot # DMA25006, Exp Date: 11/30/2028.. Units affected: 14,232 bottles (1,423,200 tablets). Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc., Princeton, NJ 08540 NDC 69452-206-20.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Presence of Foreign Tablets/Capsules
Company / brand: Bionpharma recalls
Affected product: Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg recall status
Official ID D-0822-2026 · Official record ↗
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.